ESE and ESPE launch joint transition of care guidance to improve outcomes for young people moving from child to adult endocrine care
Date: 19 February 2026
ESE and ESPE launch joint transition of care guidance to improve outcomes for young people moving from child to adult endocrine care
The European Society of Endocrinology (ESE) and the European Society for Paediatric Endocrinology (ESPE) today launch a landmark Joint Clinical Practice Guidance for Healthcare Transition from Paediatric to Adult Endocrine Care, aimed at supporting structured and effective transition of young people with endocrine conditions transferring from paediatric to adult health services.
Developed by leading clinicians, nurses and other healthcare workers from across Europe who specialise in the care of children and adult patients with endocrine disorders, the Joint Guidance provides healthcare teams with practical, evidence-based recommendations to ensure continuity, safety and quality of care at a critical phase in a patient’s life. The Guidance has been crafted in close consultation with patient advocacy organisations, reflecting ESE and ESPE’s commitment to patient-centred excellence.
The Guidance is co-published in both the European Journal of Endocrinology and Hormone Research in Paediatrics.
“Transition from paediatric to adult endocrine care presents unique clinical and psychosocial challenges,” said Sebastian Neggers, Guidance Co-Chair (ESE). “This new Guidance equips healthcare teams with clear, multidisciplinary strategies to help young people navigate this period successfully and to reduce gaps in care that can lead to poor outcomes.”
Transition periods are consistently identified as high-risk moments for disengagement from healthcare, interruptions in treatment adherence and adverse health events — especially for chronic endocrinopathies such as hypopituitarism, diabetes and disorders of growth and puberty.
Enora Le Roux, Guidance Co-Chair (ESPE) commented, “The Guidance emphasises early planning, shared decision-making, coordinated clinical handovers and education tailored to patients and families. The practical, evidence-based nature of this Guidance provides a solid foundation for broad implementation and acknowledges the central role of patients as active participants in their care journey.”
Key features of the Joint Clinical Practice Guidance on Healthcare Transition from Paediatric to Adult Endocrine Care include:
-
Structured Transition Pathways: Core steps to support transition readiness assessment, joint clinics and formal transfer planning between paediatric and adult teams.
-
Multidisciplinary Collaboration: Practical recommendations for endocrinologists, nurses, psychologists and allied health professionals to work together in designing personalised transition plans.
-
Patient-centred Communication: Guidance on involving young people and their families in care decisions, goal setting and self-management to empower autonomy and adherence.
-
Continuity and Safety Measures: Suggested tools and checklists to capture medical history, risk factors and ongoing needs to minimise care fragmentation during transfer.
The Guidance has been informed by scientific literature, expert consensus and clinical experience to reflect real-world challenges in endocrine transition care. It represents a major step towards harmonising practice across Europe and improving long-term health trajectories for adolescents and young adults with endocrine conditions. The Guidance is also endorsed by the Endocrine Society (USA).
Mehul Dattani, President, ESPE, added: “This Guidance promises to standardise and improve transition care for young Europeans with lifelong endocrine conditions. To facilitate its widespread implementation, ESE and ESPE are developing joint educational initiatives aimed at addressing real-world questions and providing specialised training for healthcare professionals across Europe, fostering excellence in transition care delivery with optimisation of care and improving outcomes for patients with endocrine conditions”.
Wiebke Arlt, President, ESE, said: “Partnership between ESE and ESPE for this Guidance underscores our shared commitment to hormone health across the life course. By bridging paediatric and adult endocrinology, we are supporting clinicians and patients through a phased, coordinated approach that values continuity, engagement and clinical excellence.
“Future efforts will focus on monitoring implementation patterns, identifying barriers and evaluating outcomes across different healthcare systems, ensuring that no young person falls through the cracks during this critical life transition.”
The Joint Clinical Practice Guidance on Healthcare Transition from Paediatric to Adult Endocrine Care is freely available online and will be accompanied by supporting educational materials for both healthcare professionals and patient communities.
More information: https://www.ese-hormones.org/publications/guidelines/
Guideline link: https://doi.org/10.1093/ejendo/lvag020
19/02/2026
Press Releases , Adrenal and Cardiovascular Endocrinology , Calcium and Bone , Diabetes, Obesity, Metabolism and Nutrition , Environmental Endocrinology , Endocrine-related Cancer , Pituitary and Neuroendocrinology , Reproductive and Developmental Endocrinology , Thyroid , Clinicians , Early Careers , (Allied) Health Professionals , Nurses , Researchers , Patients , Public , European Women in Endocrinology ,